With the growing demand for resilient, efficient, and low carbon infrastructure, increasing attention has been directed toward novel materials and ...
A key challenge in structure-based drug design is generating three-dimensional molecules while preserving essential protein-ligand interactions. We propose DiffPharma, a structure-based pharmacophore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results